| TUBA1 |
TUBA4A, TUBA1: Tubulin alpha-4A chain |
NACA |
NACA, HSD48: Nascent polypeptide-associated complex subunit alpha |
12.630 |
Evidence |
|
| YWHAZ |
YWHAZ: 14-3-3 protein zeta/delta |
ATM |
ATM: Serine-protein kinase ATM |
12.630 |
Evidence |
|
| BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
MTA1 |
MTA1: Metastasis-associated protein MTA1 |
12.630 |
Evidence |
|
| AKT1 |
AKT1, PKB, RAC: RAC-alpha serine/threonine-protein kinase |
CREBBP |
CREBBP, CBP: CREB-binding protein |
12.630 |
Evidence |
|
| POLR2A |
POLR2A: Uncharacterized protein POLR2A |
SFRS2 |
SFRS2: Splicing factor, arginine/serine-rich 2 |
12.630 |
Evidence |
|
| POLR2A |
POLR2A: Uncharacterized protein POLR2A |
YARS |
YARS: Tyrosyl-tRNA synthetase, cytoplasmic |
12.630 |
Evidence |
|
| RPA2 |
RPA2, REPA2, RPA32, RPA34: Replication protein A 32 kDa subunit |
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
12.630 |
Evidence |
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
KHDRBS1 |
KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate |
12.630 |
Evidence |
|
| TP53 |
TP53, P53: Cellular tumor antigen p53 |
RELA |
RELA, NFKB3: Transcription factor p65 |
12.630 |
Evidence |
|
| NCOR1 |
NCOR1, KIAA1047: Nuclear receptor corepressor 1 |
MTA1 |
MTA1: Metastasis-associated protein MTA1 |
12.630 |
Evidence |
|
| HDAC3 |
HDAC3: Histone deacetylase 3 |
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
12.630 |
Evidence |
|
| HDAC3 |
HDAC3: Histone deacetylase 3 |
NFKBIA |
NFKBIA, IKBA, MAD3, NFKBI: NF-kappa-B inhibitor alpha |
12.630 |
Evidence |
|
| TSNARE1 |
TSNARE1: T-SNARE domain containing 1 |
YKT6 |
YKT6: Synaptobrevin homolog YKT6 |
12.620 |
Evidence |
|
| VAMP3 |
VAMP3, SYB3: Vesicle-associated membrane protein 3 |
STX10 |
STX10, hCG_27761: Uncharacterized protein STX10 |
12.620 |
Evidence |
|
| AP2A1 |
AP2A1, ADTAA, CLAPA1: AP-2 complex subunit alpha-1 |
AP2S1 |
AP2S1, AP17, CLAPS2: AP-2 complex subunit sigma-1 |
12.620 |
Evidence |
|
| ACVR1B |
ACVR1B, ACVRLK4: Activin receptor type-1B precursor |
GMCL1L |
GMCL1L, GCL: Germ cell-less protein-like 1-like |
12.580 |
Evidence |
|
| ACVR1B |
ACVR1B, ACVRLK4: Activin receptor type-1B precursor |
GNB1 |
GNB1: Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 |
12.580 |
Evidence |
|
| ACTN4 |
ACTN4: Alpha-actinin-4 |
GRIN2A |
GRIN2A, NMDAR2A: Glutamate [NMDA] receptor subunit epsilon-1 precursor |
12.580 |
Evidence |
|
| SUMO1 |
SUMO1, SMT3C, OK/SW-cl.43, SMT3H3, UBL1: Small ubiquitin-related modifier 1 prec |
UBA2 |
SAE2, UBA2, HRIHFB2115, UBLE1B: SUMO-activating enzyme subunit 2 |
12.550 |
Evidence |
|
| FOSL2 |
FOSL2, FRA2: Fos-related antigen 2 |
BARD1 |
BARD1: BRCA1-associated RING domain protein 1 |
12.550 |
Evidence |
|
| FOSL2 |
FOSL2, FRA2: Fos-related antigen 2 |
GRK1 |
GRK1, RHOK: Rhodopsin kinase precursor |
12.550 |
Evidence |
|
| KIT |
KIT: Mast/stem cell growth factor receptor precursor |
CD44 |
IPI00305064 |
12.550 |
Evidence |
|
| PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
CD44 |
IPI00305064 |
12.550 |
Evidence |
|
| CSF1R |
CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor |
FASLG |
FASLG, APT1LG1, FASL, TNFSF6: Tumor necrosis factor ligand superfamily member 6 |
12.550 |
Evidence |
|
| CSF1R |
CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor |
MS4A1 |
MS4A1, CD20: B-lymphocyte antigen CD20 |
12.550 |
Evidence |
|